Dianthus Therapeutics Analyst Ratings
Dianthus Therapeutics Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/22/2023 | 73.58% | Wedbush | → $23 | Initiates Coverage On | → Outperform |
| 09/28/2023 | 81.13% | Raymond James | → $24 | Initiates Coverage On | → Outperform |
| 日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
|---|---|---|---|---|---|
| 11/22/2023 | 73.58% | Wedbush | → 23 美元 | 啓動覆蓋範圍開啓 | → 跑贏大盤 |
| 09/28/2023 | 81.13% | 雷蒙德·詹姆 | → 24 美元 | 啓動覆蓋範圍開啓 | → 跑贏大盤 |
What is the target price for Dianthus Therapeutics (DNTH)?
Dianthus Therapeutics（DNTH）的目標價格是多少？
The latest price target for Dianthus Therapeutics (NASDAQ: DNTH) was reported by Wedbush on November 22, 2023. The analyst firm set a price target for $23.00 expecting DNTH to rise to within 12 months (a possible 73.58% upside). 2 analyst firms have reported ratings in the last year.
Wedbush於2023年11月22日公佈了Dianthus Therapeutics（納斯達克股票代碼：DNTH）的最新目標股價。該分析公司將目標股價定爲23.00美元，預計DNTH將在12個月內升至12個月內（可能上漲73.58％）。去年有兩家分析公司公佈了評級。
What is the most recent analyst rating for Dianthus Therapeutics (DNTH)?
Dianthus Therapeutics（DNTH）的最新分析師評級是多少？
The latest analyst rating for Dianthus Therapeutics (NASDAQ: DNTH) was provided by Wedbush, and Dianthus Therapeutics initiated their outperform rating.
Dianthus Therapeutics（納斯達克股票代碼：DNTH）的最新分析師評級由Wedbush提供，Dianthus Therapeutics啓動了跑贏大盤的評級。
When is the next analyst rating going to be posted or updated for Dianthus Therapeutics (DNTH)?
Dianthus Therapeutics（DNTH）的下一次分析師評級何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Dianthus Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Dianthus Therapeutics was filed on November 22, 2023 so you should expect the next rating to be made available sometime around November 22, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括瀏覽公開財務報表，與Dianthus Therapeutics的高管和客戶交談，以及聽取業績電話會議。大多數分析師每三個月做一次這樣的評級，因此每家公司每年應該獲得4次評級。Dianthus Therapeutics的最新評級是在2023年11月22日發佈的，因此您應該預計下一個評級將在2024年11月22日左右公佈。
Is the Analyst Rating Dianthus Therapeutics (DNTH) correct?
分析師對 Dianthus Therapeutics（DNTH）的評級是否正確？
While ratings are subjective and will change, the latest Dianthus Therapeutics (DNTH) rating was a initiated with a price target of $0.00 to $23.00. The current price Dianthus Therapeutics (DNTH) is trading at is $13.25, which is within the analyst's predicted range.
儘管評級是主觀的，而且會發生變化，但最新的Dianthus Therapeutics（DNTH）評級已啓動，目標股價爲0.00美元至23.00美元。Dianthus Therapeutics（DNTH）目前的交易價格爲13.25美元，在分析師的預測區間內。